Literature DB >> 8805068

An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil.

A S Levin, C M Mendes, S I Sinto, H S Sader, C R Scarpitta, E Rodrigues, N Sauaia, M Boulos.   

Abstract

A case-control (46 cases, 23 controls) study was done to determine risk factors for an outbreak of a multiresistant Acinetobacter baumanii (only susceptible to colistin) in a university hospital. The use of antecedent antibacterials and intubation were independent risk factors. No common source was found. With control measures, the outbreak resolved gradually.

Entities:  

Mesh：

Year:  1996        PMID： 8805068     DOI： 10.1086/647319

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  15 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 3.  Multidrug-resistant organisms in military wounds from Iraq and Afghanistan.

Authors:  Jason H Calhoun; Clinton K Murray; M M Manring
Journal:  Clin Orthop Relat Res       Date:  2008-03-18       Impact factor: 4.176

4.  Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.

Authors:  Hsien Chang Chang; Yu Fang Wei; Lenie Dijkshoorn; Mario Vaneechoutte; Chung Tao Tang; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Molecular typing of Acinetobacter baumannii from ten different intensive care units of a university hospital.

Authors:  E Presterl; R Nadrchal; S Winkler; A Makristathis; W Koller; M L Rotter; A M Hirschl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

6.  Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune.

Authors:  Velu Nair; Dinesh Sharma; A K Sahni; Naveen Grover; S Shankar; S S Jaiswal; S S Dalal; D R Basannar; Vivek S Phutane; Atul Kotwal; G Gopal Rao; Deepak Batura; M D Venkatesh; Tapan Sinha; Sushil Kumar; D P Joshi
Journal:  Med J Armed Forces India       Date:  2015-02-25

7.  Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Authors:  Libera M Dalla-Costa; Juliana M Coelho; Helena A P H M Souza; Maria E S Castro; Christiane J N Stier; Karin L Bragagnolo; Alvaro Rea-Neto; Sergio R Penteado-Filho; David M Livermore; Neil Woodford
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria.

Authors:  John P Ouderkirk; Jill A Nord; Glenn S Turett; Jay Ward Kislak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance.

Authors:  Stilianos Katsaragakis; Haridimos Markogiannakis; Konstantinos G Toutouzas; Panagiotis Drimousis; Andreas Larentzakis; Eleni-Maria Theodoraki; Dimitrios Theodorou
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

10.  Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.

Authors:  Teena Chopra; Dror Marchaim; Paul C Johnson; Reda A Awali; Hardik Doshi; Indu Chalana; Naomi Davis; Jing J Zhao; Jason M Pogue; Sapna Parmar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.